4DMedical Limited (ASX:4DX) has locked in a three-year contract extension with the prestigious Cleveland Clinic, ensuring continued use of its functional lung imaging software. The deal, valued at a minimum…
PolyNovo Responds to ‘Margin Call’ Article on CEO Transition
PolyNovo Limited (ASX: PNV) has addressed recent media speculation regarding its leadership transition, confirming that CEO Swami Raote has been asked to step down, with his employment set to officially…
Duxton Water Sells $121.3M in Water Entitlements to Australian Government
Duxton Water (ASX: D2O) has struck a $121.3 million deal to sell 30,614 megalitres of water entitlements to the Australian Federal Government, supporting environmental flows in the Murray-Darling Basin. The…
Pro Medicus Signs $40M, 7-Year Contract with LucidHealth
Pro Medicus Limited (ASX: PME) has inked a A$40 million, seven-year deal with LucidHealth, a major U.S. radiology provider, marking another significant step in PME’s North American expansion. What’s in…
PEXA Delivers Strong Revenue Growth and Announces $50M Buyback
PEXA Group (ASX: PXA) has posted an impressive set of first-half results for FY25, with revenue and operating EBITDA both climbing by 25% and 24%, respectively. However, statutory net profit…
Life360 Delivers Record Q4 and Full-Year 2024 Results
Massive Growth in Users and Revenue as Company Sets Sights on $1 Billion Milestone Life360 (NASDAQ: LIF, ASX: 360) has wrapped up 2024 with a bang, reporting record-breaking results for…
Medibank Delivers Strong Half-Year Results, Focuses on Growth and Healthcare Evolution
Medibank has reported a strong financial performance for the first half of 2025, demonstrating resilience, customer focus, and a clear strategy to expand its role as a health company. CEO…
Woolworths Group Sees Challenging H1, Focuses on Clear Priorities for 2025
Woolworths Group (ASX: WOW) has reported its first-half FY25 results, navigating a tough start to the year impacted by industrial action, cost pressures, and increased promotional investment. Despite these headwinds,…
Appen (ASX: APX) Reports FY24 Results: A Year of Transformation and Growth
Appen Limited has wrapped up a transformative 2024, bouncing back from challenges to return to revenue growth in the second half of the year. With a strong focus on cost…
4DMedical (ASX: 4DX) Secures Regulatory Approval for CT LVAS™ in Canada
Expansion into Canadian Market Strengthens Global Footprint Respiratory imaging pioneer 4DMedical (ASX: 4DX) has just scored a major regulatory win, securing Health Canada approval for its CT Lung Ventilation Analysis…